| Literature DB >> 36240832 |
Lindsay Nelson1, Honghan Ye2, Anna Schwenn1, Shinhyo Lee1, Salsabil Arabi1, B Ian Hutchins3.
Abstract
Scientists have expressed concern that the risk of flawed decision making is increased through the use of preprint data that might change after undergoing peer review. This Health Policy paper assesses how COVID-19 evidence presented in preprints changes after review. We quantified attrition dynamics of more than 1000 epidemiological estimates first reported in 100 preprints matched to their subsequent peer-reviewed journal publication. Point estimate values changed an average of 6% during review; the correlation between estimate values before and after review was high (0·99) and there was no systematic trend. Expert peer-review scores of preprint quality were not related to eventual publication in a peer-reviewed journal. Uncertainty was reduced during peer review, with CIs reducing by 7% on average. These results support the use of preprints, a component of biomedical research literature, in decision making. These results can also help inform the use of preprints during the ongoing COVID-19 pandemic and future disease outbreaks.Entities:
Mesh:
Year: 2022 PMID: 36240832 PMCID: PMC9553196 DOI: 10.1016/S2214-109X(22)00368-0
Source DB: PubMed Journal: Lancet Glob Health ISSN: 2214-109X Impact factor: 38.927
Figure 1Robustness of preprint data during review
Log scale comparison of epidemiological estimate values reported in preprints vs their matched values reported in peer-reviewed publications (R>0·99).
Figure 2Correlates of peer review
(A) Rug plot and line plot of fitted logistic regression controlling for area of research. 10% jitter was added to the x-axis rug plot data points to facilitate visualisation of otherwise overlapping points. (B) Sorted ratios of the peer-reviewed point estimates to the matched preprint value. (C) Sorted ratios of the CI range in the published vs preprint versions of articles. Grey lines indicate the tenth and ninetieth quantiles.